In situ measurement of linezolid and vancomycin concentrations in intravascular catheter-associated biofilm
Authors:
- Mark H. WilcoxMWMark H. Wilcox
- Peter KitePKPeter Kite
- Kerry MillsKMKerry Mills
- Sarah SugdenSSSarah Sugden
Open Access
- 1 February 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 47 (2) , 171-175
Abstract
We describe a new method for the measurement of antimicrobial concentrations in the biofilm associated with the endoluminal surface of intravascular catheters. We quantified endoluminal planktonic bacteria in haemodialysis catheters using the acridine orange method on catheter blood. After catheter removal, separate lumens were perfused in vitro with either vancomycin or linezolid to simulate in vivo antibiotic infusion. Biofilm was recovered using endoluminal brushes, weighed and assayed by fluoroimmunoassay for vancomycin and by bioassay for linezolid. Viable bacteria were counted by serial dilution and agar plating. Biofilm had measurable amounts of vancomycin in 11/11 catheter lumens post-infusion (0.3–18.2 mg biofilm per lumen, mean 6.8 mg; vancomycin concentration 0.2–89 mg/g biofilm, median 19 mg/g). By comparison, linezolid was detected in 4/11 catheter lumens post-infusion (0.5–18.1 mg biofilm per lumen, mean 5.9 mg; linezolid concentration 0.9–6.1 mg/g biofilm, median 1.5 mg/g). Percentage reductions in biofilm-associated bacterial counts post-antibiotic were 84–100%, median 95% (vancomycin) and 0–98%, median 91% (linezolid). We found a significant difference (P = 0.05; Wilcoxon rank sum test) in vancomycin concentrations in coagulase-negative staphylococcal biofilm (median 17.0 mg/g, mean 27.9 mg/g) compared with glycopeptide levels found in biofilm associated with other microorganisms (median 5.5 mg/g, mean 6.9 mg/g). Biofilm concentrations of vancomycin are generally higher than linezolid after antibiotic infusion, which can be explained partly by glycopeptide binding to glycocalyx. Neither antibiotic achieved consistent 100% kill of biofilm bacteria after single infusions, even when a very high concentration was present. The endoluminal brush technique can be used to measure antibiotic concentration in intravascular catheter-associated biofilm in situ. This approach can be exploited to measure biofilm antibiotic concentrations in vivo, without the need for catheter removal.Keywords
This publication has 20 references indexed in Scilit:
- Rapid diagnosis of central-venous-catheter-related bloodstream infection without catheter removalThe Lancet, 1999
- Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patientsKidney International, 1998
- Mathematical model of -lactam penetration into a biofilm of Pseudomonas aeruginosa while undergoing simultaneous inactivation by released -lactamasesJournal of Antimicrobial Chemotherapy, 1996
- Vancomycin Penetration Into Biofilm Covering Infected Prostheses And Effect On BacteriaThe Journal of Infectious Diseases, 1994
- Binding of teicoplanin and vancomycin to polymer surfacesJournal of Antimicrobial Chemotherapy, 1994
- Rapid diagnosis of central venou catheter sepsisThe Lancet, 1993
- Effect of biofilm culture upon the susceptibility of Staphylococcus epidermidis to tobramycinJournal of Antimicrobial Chemotherapy, 1992
- Slime production and adherence by coagulase-negative staphylococciJournal of Hospital Infection, 1991
- Susceptibility of bacterial biofilms to tobramycin: role of specific growth rate and phase in the division cycleJournal of Antimicrobial Chemotherapy, 1990
- Staphylococcus epidermidis Extracted Slime Inhibits the Antimicrobial Action of Glycopeptide AntibioticsThe Journal of Infectious Diseases, 1990